- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetic Peripheral Neuropathy in Ireland
Total 595 results
-
PfizerCompletedDiabetes, Type 2Canada, United States, Korea, Republic of, Taiwan, Mexico, Hungary, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, United Kingdom, Canada, Sweden, Ireland, Argentina, Brazil, Lebanon, Malaysia, Mexico, Italy
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusCzech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, France, Mexico
-
TakedaTerminatedDiabetes MellitusUnited States
-
VA Office of Research and DevelopmentCompletedDiabetes InsipidusUnited States
-
Eli Lilly and CompanyRecruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c LevelCzech Republic, Poland, Spain, Germany, Canada, Slovakia
-
National Cancer Institute (NCI)TerminatedHigh Grade Sarcoma | Metastatic Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Leiomyosarcoma | Myxofibrosarcoma | Metastatic Malignant Peripheral Nerve Sheath Tumor | Metastatic Synovial Sarcoma | Metastatic Undifferentiated... and other conditionsUnited States
-
PfizerTerminatedDiabetes Mellitus, Type 1Denmark, Spain, Sweden, United States, Belgium, Austria, France, Portugal, Ireland, United Kingdom, Finland, Netherlands, Norway
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Germany, Poland, Argentina, United Kingdom, Mexico
-
Harvest TechnologiesTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Germany, United Kingdom, Austria, Belgium, France, Ireland
-
Washington University School of MedicineMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsCompletedVenous Thrombosis | Deep Vein Thrombosis | Postphlebitic Syndrome | Venous Thromboembolism | Post Thrombotic SyndromeUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm in the Bone | Peripheral Primitive Neuroectodermal Tumor of Soft Tissues | Metastatic Malignant Neoplasm in the Lung | Metastatic Ewing Sarcoma | Metastatic Malignant Neoplasm in the Bone Marrow | Metastatic Peripheral Primitive Neuroectodermal Tumor of BoneUnited States, Canada, Puerto Rico
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, Netherlands, Austria, Spain, France, Germany, Ireland, Switzerland, Finland
-
Andromeda Biotech Ltd.CompletedType 1 Diabetes MellitusUnited States, Russian Federation, Israel, Spain, Lithuania, Germany, Austria, Belarus, Canada, Czech Republic, Finland, Hungary, Italy, Poland
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2France, United States, Mexico, United Kingdom, Spain, Canada, New Zealand, Thailand, Russian Federation, Brazil, Germany, Australia, Poland, Slovakia, Peru, Ukraine, South Africa, Costa Rica, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Russian Federation, United Kingdom, France, Ukraine
-
InteKrin Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
AstraZenecaTerminatedType 2 DiabetesFrance, Korea, Republic of, South Africa, Spain, United Kingdom, Vietnam, Norway, Israel, Philippines, Australia
-
Akros Pharma Inc.TerminatedType II Diabetes MellitusUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Canada
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Israel, Italy, Russian Federation, United Kingdom, Denmark, Austria, Serbia, Canada, Croatia, Australia, Greece, Ireland, Brazil, Spain, Argentina
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Denmark, Canada, France, Netherlands, Austria, Israel, Finland, Russian Federation, Croatia, Bulgaria, Poland, Ireland, Spain, Norway, Greece, Argentina, Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Japan, China, Puerto Rico, Romania, Brazil
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedDiabetes Mellitus, Type 2 | Erectile DysfunctionUnited States, Canada
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, Mexico, Puerto Rico
-
Bristol-Myers SquibbCompletedDiabetes, Type 2United States, Canada, Mexico, Puerto Rico, Australia, Poland, Taiwan
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United Kingdom, Australia, Canada, Thailand, India
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway
-
St. Anna KinderkrebsforschungRecruitingNeuroblastomaNorway, Czechia, United Kingdom, France, Spain, Belgium, Switzerland, Hungary, Israel, Australia, Italy, Austria, Denmark, Greece, Ireland, Poland, Portugal, Slovakia, Slovenia, Sweden
-
Hanmi Pharmaceutical Company LimitedSanofiCompletedType 2 Diabetes MellitusUnited States, Germany, Poland, Ukraine, United Kingdom
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, China, Italy, Japan, India, Poland, South Africa, Turkey, Greece, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
Forest LaboratoriesPhenomixTerminatedDiabetes Mellitus, Type IIUnited States, Belarus, India, Romania, Germany, Lithuania
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Spain, Denmark, Austria, Belgium, Serbia, Germany, Canada, France, Finland, Norway, Czech Republic
-
Giselle ShollerBeat NB Cancer Foundation; Team Parker for LifeRecruiting
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Boston Children's HospitalCompletedSarcoma | Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Neuroblastoma | Central Nervous System Tumor, PediatricUnited States